Search Results - "Carrasquilla, Michael"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Safety and early efficacy of involved-field SBRT for nodal oligo-recurrent prostate cancer by Koh, Min Ji, Pilkington, Padraig, Koh, Min Jung, Lawlor, Mary-Kate, Creswell, Michael, O'Connor, Timothy, Zwart, Alan, Danner, Malika, Kumar, Deepak, Suy, Simeng, Carrasquilla, Michael, Collins, Sean P

    Published in Frontiers in oncology (17-10-2024)
    “…Following treatment for localized prostate cancer, a subset of men will develop recurrent disease in the abdominopelvic nodes. For radiation therapy (RT), the…”
    Get full text
    Journal Article
  2. 2

    Comparative analysis of plan quality and delivery efficiency: ZAP-X vs. CyberKnife for brain metastases treatment by Niu, Ying, Rashid, Abdul, Lee, Jui-Min, Carrasquilla, Michael, Conroy, Dylan R, Collins, Brian T, Satinsky, Andrew, Unger, Keith R, Pang, Dalong

    Published in Frontiers in oncology (12-06-2024)
    “…ZAP-X, a novel and dedicated radiosurgery (SRS) system, has recently emerged, while CyberKnife has solidified its position as a versatile solution for SRS and…”
    Get full text
    Journal Article
  3. 3

    Novel Paired Normal Prostate and Prostate Cancer Model Cell Systems Derived from African American Patients by Jung, Mira, Kowalczyk, Keith, Hankins, Ryan, Bandi, Gaurav, Kallakury, Bhaskar, Carrasquilla, Michael A, Banerjee, Partha P, Grindrod, Scott, Dritschilo, Anatoly

    Published in Cancer research communications (01-12-2022)
    “…Prostate cancer is the most frequently diagnosed solid malignancy in men. African American (AA) men are at greater risk for developing prostate cancer, and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy by Burke, Aidan M, Carrasquilla, Michael, Jean, Walter C, Collins, Brian T, Anaizi, Amjad N, Atkins, Michael B, Gibney, Geoffrey T, Collins, Sean P

    Published in Frontiers in oncology (12-01-2022)
    “…Clinical trials of anti-Programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte-associated protein (CTLA-4) therapies have demonstrated a clinical…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Self-Reported Burden in Elderly Patients With Localized Prostate Cancer Treated With Stereotactic Body Radiation Therapy (SBRT) by Aghdam, Nima, Pepin, Abigail, Carrasquilla, Michael, Johnson, Colin, Danner, Malika, Ayoob, Marilyn, Yung, Thomas, Lei, Siyuan, Collins, Brian T, Kumar, Deepak, Suy, Simeng, Lynch, John, Collins, Sean P

    Published in Frontiers in oncology (22-01-2020)
    “…Retaining quality of life in patients treated with SBRT for prostate cancer remains paramount. As such, balancing the benefits of treatment against the effects…”
    Get full text
    Journal Article
  10. 10
  11. 11

    High-Risk Non-Small Cell Lung Cancer Treated With Active Scanning Proton Beam Radiation Therapy and Immunotherapy by Carrasquilla, Michael, Paudel, Nitika, Collins, Brian T., Anderson, Eric, Krochmal, Rebecca, Margolis, Marc, Balawi, Ahssan, DeBlois, David, Giaccone, Giuseppe, Kim, Chul, Liu, Stephen, Lischalk, Jonathan W.

    Published in Advances in radiation oncology (01-03-2023)
    “…Non-small cell lung cancer (NSCLC) is a deadly malignancy that is frequently diagnosed in patients with significant medical comorbidities. When delivering…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Dosimetric predictors of acute bowel toxicity after Stereotactic Body Radiotherapy (SBRT) in the definitive treatment of localized prostate cancer by Repka, Michael C, Carrasquilla, Michael, Paydar, Ima, Wu, Binbin, Lei, Siyuan, Suy, Simeng, Collins, Sean P, Kole, Thomas P

    Published in Acta oncologica (01-02-2023)
    “…SBRT is an increasingly popular treatment for localized prostate cancer, though considerable variation in technical approach is common and optimal dose…”
    Get more information
    Journal Article
  19. 19
  20. 20